Literature DB >> 3622597

The interaction of erythromycin with theophylline.

O Paulsen, P Höglund, L G Nilsson, H I Bengtsson.   

Abstract

We have studied the interaction of erythromycin with theophylline. We gave ten healthy volunteers theophylline as an intravenous loading dose (5 mg X kg-1) over 1 h, followed by a maintenance infusion (0.5 mg X kg-1 X h-1) for 5 h. A second infusion of theophylline was given after 9 days of treatment with 1 g erythromycin base daily, and the concentrations of theophylline were determined during the infusion periods. The concentrations of erythromycin were measured for 8 h, after one week of treatment, and also after the last erythromycin dose, simultaneously with the second theophylline infusion. Concentrations within the therapeutic range were obtained with both drugs. A significant increase in both AUC and mean plasma concentrations of theophylline was seen during erythromycin treatment. The plasma clearance of theophylline was reduced in 9 of the 10 subjects. Renal clearance increased correspondingly, but the change was not statistically significant. Serum concentrations of erythromycin fell significantly, by more than 30%, with concurrent theophylline medication. We conclude that an interaction between theophylline and erythromycin, affecting both drugs, can be shown with concentrations of the drugs within the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622597     DOI: 10.1007/bf00637676

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Theophylline determinations.

Authors:  L H Cummins; P P Kozak; S A Gillamn
Journal:  Ann Allergy       Date:  1976-12

2.  Administration of erythromycin to patients on theophylline.

Authors:  P P Kozak; L H Cummins; S H Gillman
Journal:  J Allergy Clin Immunol       Date:  1977-08       Impact factor: 10.793

Review 3.  Pharmacokinetic drug interactions with macrolide antibiotics.

Authors:  J Descotes; P André; J C Evreux
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

4.  Steady state urinary excretion of theophylline and its metabolites in the presence of erythromycin.

Authors:  S Melethil; A Dutta; P B Ryan; S K Pingleton; S J Kelly
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-02

5.  The effect of erythromycin on theophylline pharmacokinetics at steady state.

Authors:  M S Maddux; N H Leeds; H W Organek; G R Hasegawa; J L Bauman
Journal:  Chest       Date:  1982-05       Impact factor: 9.410

Review 6.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

7.  Lack of clinically important interaction between erythromycin and theophylline.

Authors:  R Hildebrandt; U Gundert-Remy; H Möller; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  Pharmacokinetic interactions of the macrolide antibiotics.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

9.  Aminophylline blood levels with concomitant erythromycin therapy in relapsed chronic obstructive lung disease.

Authors:  M Vercelloni; R Cogo; A Albertini; M Granata; F Rosaschino
Journal:  J Int Med Res       Date:  1986       Impact factor: 1.671

10.  Dose-dependent elimination kinetics of theophylline.

Authors:  L J Lesko
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

View more
  4 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

Review 2.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 3.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

Review 4.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.